ArticleBiochemistry and biophysics reports2026
Surface protein profiling reveals depot-specific features of subcutaneous and visceral adipose progenitor cells.
Article in Biochemistry and biophysics reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
White adipose tissue is organized into anatomically and functionally distinct depots, yet the mechanisms by which intrinsic differences between subcutaneous and visceral adipose progenitor cells (APCs) contribute to depot-specific inflammatory and remodeling properties remain unresolved. Here, by directly comparing APCs isolated from subcutaneous and visceral fat, we identify distinct surface protein programs underlying their divergent functional properties. Subcutaneous APCs exhibited elevated expression of galectin-9, CD44, and CD63, defining functional programs governing immune modulation, adipogenesis, and exosome-mediated stress adaptation. Functional assays revealed that galectin-9 promotes an anti-inflammatory phenotype, CD44 quantitatively modulates adipogenic differentiation, and CD63 enhances exosome release and confers resistance to iron-induced cellular stress. Notably, several depot-specific features were not evident at the transcriptomic level, underscoring the importance of surface protein-level regulation. Together, our findings demonstrate that APC surface protein signatures distinguish subcutaneous from visceral fat, establishing a mechanistic link between depot identity, tissue remodeling, and metabolic disease susceptibility.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.